题名 | Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial. |
杂志 | Lancet. |
年|卷|期 | 2013 Mar 9;381(9869) |
页码 | 836-44 |
链接 | http://www.ncbi.nlm.nih.gov/pubmed/23332165 |
欢迎光临 科研速递论坛 (http://www.expaper.cn/) | Powered by Discuz! X2.5 |